BBIL partners with Bilthoven Biologicals to boost OPV production
The Indian Express — April 2, 2024, 10:00 AM UTC
Summary: Bharat Biotech International Limited (BBIL) has partnered with Bilthoven Biologicals B.V. to enhance Oral Polio Vaccine (OPV) production and supply. BBIL will procure drug substances for OPV production, ensuring supply within India and globally. This collaboration aims to strengthen vaccine production and supply security.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.